全球食物過敏診斷和治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計食品過敏診斷和治療市場將從 2025 年的 100.1 億美元成長到 2034 年的 208.5 億美元，2026 年至 2034 年的複合年成長率為 8.49%。

隨著全球食物過敏盛行率的上升，食物過敏診斷和治療的全球市場正在迅速擴張。對花生、牛奶、雞蛋和貝類等食物的過敏反應越來越常見，尤其是在兒童身上。這一日益嚴重的健康問題推動了對精準診斷測試和有效治療方案的需求，以控制和預防嚴重的過敏反應。

診斷技術的進步在提高過敏檢測的準確性方面發揮了至關重要的作用。血液檢測、皮膚點刺試驗和分子診斷工具正在幫助醫療專業人員更準確地識別特定過敏原。同時，研究人員正在探索創新的治療方法，例如免疫療法和生物療法，旨在隨著時間的推移降低過敏易感性。

隨著全球對食物過敏的認知不斷提高，預計未來市場將持續成長。世界各國政府和醫療機構都在積極推廣早期診斷和管理策略，以減少過敏相關併發症。新興國家對過敏治療的持續研究以及醫療服務的拓展，將為市場的長期成長提供支撐。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球食物過敏診斷與治療市場：依產品分類

• 市場分析、洞察與預測
• 診斷
• 治療藥物

第5章 全球食物過敏診斷與治療市場：依過敏原類型分類

• 市場分析、洞察與預測
• 花生
• 牛奶
• 蛋
• 魚
• 甲殼類動物
• 堅果和種子
• 小麥
• 大豆
• 其他

第6章：全球食物過敏診斷與治療市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 學術研究機構
• 診斷檢測實驗室

第7章 全球食物過敏診斷與治療市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Astellas Pharma Inc
  • Aimmune Therapeutics
  • Meridian Medical Technologies
  • Medeca Pharma AB
  • BioMAfA（C）Rieux SA
  • Omega Diagnostics Group PLC
  • Camallergy（Cambridge Allergy Ltd）
  • Immunomic Therapeutics Inc
  • Prota Therapeutics Pty Ltd
  • ALK-AbellAfA3 A/S
  • HYCOR Biomedical
  • HOB Biotech Group Corp. Ltd

The Food Allergy Diagnostics And Therapeutics Market size is expected to reach USD 20.85 Billion in 2034 from USD 10.01 Billion (2025) growing at a CAGR of 8.49% during 2026-2034.

The global food allergy diagnostics and therapeutics market is expanding rapidly due to the increasing prevalence of food allergies worldwide. Allergic reactions to foods such as peanuts, milk, eggs, and shellfish have become more common, particularly among children. This growing health concern is driving demand for accurate diagnostic tests and effective therapeutic solutions to manage and prevent severe allergic reactions.

Advancements in diagnostic technologies are playing a crucial role in improving allergy detection. Blood tests, skin prick tests, and molecular diagnostic tools are helping healthcare professionals identify specific allergens more accurately. At the same time, researchers are exploring innovative treatment approaches such as immunotherapy and biologic therapies that aim to reduce allergic sensitivity over time.

Future growth in the market is expected as awareness about food allergies continues to increase globally. Governments and healthcare organizations are promoting early diagnosis and improved management strategies to reduce allergy-related complications. Continuous research in allergy therapeutics and expanding healthcare services in emerging economies will likely support long-term market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Diagnostics
• Therapeutics

By Allergen Source

• Peanuts
• Milk
• Eggs
• Fish
• Shellfish
• Tree Nuts
• Wheat
• Soy
• Others

By End-use

• Hospitals And Clinics
• Academic Research Institutes
• Diagnostics Laboratories

COMPANIES PROFILED

• Astellas Pharma Inc, Aimmune Therapeutics, Meridian Medical Technologies, Medeca Pharma AB, bioMrieux SA, Omega Diagnostics Group PLC, Camallergy Cambridge Allergy Ltd, Immunomic Therapeutics Inc, Prota Therapeutics Pty Ltd, ALKAbell AS, HYCOR Biomedical, HOB Biotech Group Corp Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: BY ALLERGEN SOURCE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Allergen Source
• 5.2. Peanuts Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Milk Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Eggs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Fish Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Shellfish Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Tree Nuts Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Wheat Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Soy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Allergen Source
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Allergen Source
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Allergen Source
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Allergen Source
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Allergen Source
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Astellas Pharma Inc
  • 9.2.2 Aimmune Therapeutics
  • 9.2.3 Meridian Medical Technologies
  • 9.2.4 Medeca Pharma AB
  • 9.2.5 BioMAfA(C)Rieux SA
  • 9.2.6 Omega Diagnostics Group PLC
  • 9.2.7 Camallergy (Cambridge Allergy Ltd)
  • 9.2.8 Immunomic Therapeutics Inc
  • 9.2.9 Prota Therapeutics Pty Ltd
  • 9.2.10 ALK-AbellAfA3 A/S
  • 9.2.11 HYCOR Biomedical
  • 9.2.12 HOB Biotech Group Corp. Ltd